CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,882,000 | +1169.6% | 55,782 | +508.5% | 0.00% | – |
| Q2 2022 | $227,000 | -86.4% | 9,167 | -71.9% | 0.00% | -100.0% |
| Q1 2021 | $1,669,000 | +64.1% | 32,577 | +98.3% | 0.00% | – |
| Q4 2020 | $1,017,000 | +24.2% | 16,427 | +9.9% | 0.00% | – |
| Q3 2020 | $819,000 | -20.8% | 14,942 | -86.6% | 0.00% | – |
| Q2 2019 | $1,034,000 | -71.5% | 111,227 | -57.4% | 0.00% | -100.0% |
| Q1 2019 | $3,631,000 | +25.8% | 261,396 | -1.2% | 0.00% | +100.0% |
| Q4 2018 | $2,886,000 | +69.9% | 264,496 | +96.8% | 0.00% | 0.0% |
| Q3 2018 | $1,699,000 | +83.5% | 134,387 | +91.1% | 0.00% | – |
| Q2 2018 | $926,000 | +30766.7% | 70,321 | +11428.0% | 0.00% | – |
| Q3 2014 | $3,000 | – | 610 | +1933.3% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 30 | -98.0% | 0.00% | – |
| Q3 2013 | $9,000 | -59.1% | 1,532 | 0.0% | 0.00% | – |
| Q2 2013 | $22,000 | – | 1,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |